| abstract |
Novel nucleic acid sequences, vectors, cells, binding agents, peptides, and pharmaceutical compositions are provided that are useful, for example, as drugs for preventing or treating cancer or viral infections associated with impaired HLA class I antigen presentation. Corresponding methods and uses are also provided. |